ArticleThe oncologist2025

Response to a novel type II RAF inhibitor in diffuse leptomeningeal glioneuronal tumor with BRAF fusion.

Brie M Chun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.